Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MOR - Morphosys AG - ADR

Close
18.96
0.450   2.373%

Share volume: 19,165
Last Updated: Fri 02 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$18.51
0.45
2.43%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 6%
Dept financing 7%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.99%
1 Month
4.18%
3 Months
5.98%
6 Months
71.27%
1 Year
144.65%
2 Year
233.80%
Key data
Stock price
$18.96
P/E Ratio 
0.00
DAY RANGE
$18.38 - $19.15
EPS 
$0.00
52 WEEK RANGE
$4.18 - $19.50
52 WEEK CHANGE
$1.45
MARKET CAP 
2.856 B
YIELD 
N/A
SHARES OUTSTANDING 
150.621 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.05
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$16,972
AVERAGE 30 VOLUME 
$25,655
Company detail
CEO: Jean-Paul Kress
Region: US
Website: https://www.morphosys.de/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US.

Recent news